You read the Monash MCT study that showed no statistical significance between tpm and tpgs with MCT bioavailability
You've read the spokesperson for the Lambert Initiative saying there was no quality evidence supporting cbd mitigating insomnia
Can you amagine a big pharma' procurement director accepting paying a huge price premium on a solubilizer that hasn't proven superior performance to tpgs ? Yep that's what you call differentiation !
Sorry but imo this exercise isn't going to mitigate your loss .
You read the Monash MCT study that showed no statistical...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 44954072 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 46237350 | 29 |
View Market Depth
| Last trade - 11.42am 27/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable